Systemic Treatment Options for Brain Metastases from Non –Small-Cell Lung Cancer
In this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Ajaz Bulbul, MD Ayesha Murtuza, MD Brian Woodward David S. Ettinger, MD Fernando Lopez-Diaz, PhD Hannah Yang Hatim Husain, MD Ingmar Bastian Parissa K. Ferguson, MS Patrick M. Forde, MD Tags: Lung Cancer Oncology Journal Review Article Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Immunotherapy | Lung Cancer | Neurology